Translational research - traffic on the bridge

被引：7

作者：

Bast, RC

Mills, GB

Young, RC

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA

来源：

BIOMEDICINE & PHARMACOTHERAPY | 2001年 / 55卷 / 9-10期

关键词：

D O I：

10.1016/S0753-3322(01)00144-5

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

[No abstract available]

引用

页码：565 / 571

页数：7

共 11 条

[1] ARDEKANI AM, 2001, P SOC GYNECOL ONCOL, V32, P102
[2] Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
Druker, BJ
Talpaz, M
Resta, DJ
Peng, B
Buchdunger, E
Ford, JM
Lydon, NB
Kantarjian, H
Capdeville, R
Ohno-Jones, S
Sawyers, CL
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) : 1031 - 1037
[3] Hu LM, 2000, CLIN CANCER RES, V6, P880
[4] Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.
Joensuu, H
Roberts, PJ
Sarlomo-Rikala, M
Andersson, LC
Tervahartiala, P
Tuveson, D
Silberman, SL
Capdeville, R
Dimitrijevic, S
Druker, B
Demetri, GD
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) : 1052 - 1056
[5] Ovarian cancer screening in the general population: current status
Menon, U
Jacobs, IJ
[J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2001, 11 : 3 - 6
[6] Selection of active drugs for ovarian cancer based on CA-125 and standard response rates in phase II trials
Rustin, GJS
Nelstrop, AE
Bentzen, SM
Bond, SJ
McClean, P
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (08) : 1733 - 1739
[7] PIK3CA is implicated as an oncogene in ovarian cancer
Shayesteh, L
Lu, YL
Kuo, WL
Baldocchi, R
Godfrey, T
Collins, C
Pinkel, D
Powell, B
Mills, GB
Gray, JW
[J]. NATURE GENETICS, 1999, 21 (01) : 99 - 102
[8] Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
Slamon, DJ
Leyland-Jones, B
Shak, S
Fuchs, H
Paton, V
Bajamonde, A
Fleming, T
Eiermann, W
Wolter, J
Pegram, M
Baselga, J
Norton, L
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (11) : 783 - 792
[9] The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis
Steinbach, G
Lynch, PM
Phillips, RKS
Wallace, MH
Hawk, E
Gordon, GB
Wakabayashi, N
Saunders, B
Shen, Y
Fujimura, T
Su, LK
Levin, B
Godio, L
Patterson, S
Rodriguez-Bigas, MA
Jester, SL
King, KL
Schumacher, M
Abbruzzese, J
DuBois, RN
Hittelman, WN
Zimmerman, S
Sherman, JW
Kelloff, G
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (26) : 1946 - 1952
[10] Wu XF, 2000, CANCER EPIDEM BIOMAR, V9, P1021

← 1 2 →